Join the 200th Anniversary Celebration

Original Article

Variability of Body Weight and Health Outcomes in the Framingham Population

Lauren Lissner, Ph.D., Patricia M. Odell, Ph.D., Ralph B. D'Agostino, Ph.D., Joseph Stokes, III, M.D., Bernard E. Kreger, M.D., Albert J. Belanger, M.A., and Kelly D. Brownell, Ph.D.

N Engl J Med 1991; 324:1839-1844June 27, 1991

Abstract
Abstract

Background.

Fluctuation in body weight is a common phenomenon, due in part to the high prevalence of dieting. In this study we examined the associations between variability in body weight and health end points in subjects participating in the Framingham Heart Study, which involves follow-up examinations every two years after entry.

Methods.

The degree of variability of body weight was expressed as the coefficient of variation of each subject's measured body-mass-index values at the first eight biennial examinations during the study and on their recalled weight at 25 years of age. Using the 32-year follow-up data, we analyzed total mortality, mortality from coronary heart disease, and morbidity due to coronary heart disease and cancer in relation to intraindividual variation in body weight, including only end points that occurred after the 10th biennial examination. We used age-adjusted proportional-hazards regression for the data analysis.

Results.

Subjects with highly variable body weights had increased total mortality (P = 0.005 for men, P = 0.01 for women), mortality from coronary heart disease (P = 0.009 for men, P = 0.009 for women), and morbidity due to coronary heart disease (P = 0.0009 for men, P = 0.006 for women). Using a multivariate analysis that also controlled for obesity, trends in weight over time, and five indicators of cardiovascular risk, we found that the positive associations between fluctuations in body weight and end points related to mortality and coronary heart disease could not be attributed to these potential confounding factors. The relative risks of these end points in subjects whose weight varied substantially, as compared with those whose weight was relatively stable, ranged from 1.27 to 1.93.

Conclusions.

Fluctuations in body weight may have negative health consequences, independent of obesity and the trend of body weight over time. (N Engl J Med 1991;324:1839–44.)

Media in This Article

Figure 1Chronology and Schematic Representation of Body-Weight Variables for a Hypothetical Subject.
Table 1Characteristics of the Subjects during the Observation Period.*
Article

BODY weight can fluctuate for a variety of reasons, one of which is dieting with the goal of weight reduction and the subsequent regaining of the weight that was lost. Because repeated episodes of weight loss and gain are so common, it is important to examine the implications for health of this pattern, which we refer to as weight cycling. The results of a study of employees of the Western Electric Company indicated that a single cycle of weight gain and loss in men was a risk factor for death from coronary heart disease, but not for death from all causes.1 The Gothenburg Prospective Studies found that variability in body weight measured at three time points was a risk factor for subsequent coronary heart disease in men and for total mortality in both men and women.2 In contrast, no significant associations between fluctuations in body weight and mortality were detected in two other cohorts.3 , 4 Three of these studies1 2 3 were limited by the fact that only a single cycle of weight fluctuation was represented in the indicators of variability of body weight used by the investigators.

These studies demonstrate the importance of investigating further the associations between fluctuations in body weight and health, and they underscore the challenges of doing such research. In overweight persons, voluntary weight reduction is assumed to be beneficial to health, whereas involuntary weight loss often reflects serious disease. Conversely, weight gain may lead to obesity and its concomitant adverse effects, yet some increments in body weight occur normally in healthy persons as they age. Fluctuations in weight that precede disease must be distinguished from those caused by disease. We addressed these issues by studying the associations between the degree of variability in body weight and subsequent health outcomes in subjects participating in the Framingham Heart Study.

Methods

Data Collection

The Framingham Heart Study offers a valuable opportunity for the analysis of fluctuations in body weight in relation to the subsequent incidence of chronic disease. This prospective study contains more data on measured body weight and uses longer follow-up periods than much of the previous work on weight fluctuations and health. Since 1948, the health status of 5127 male and female residents of Framingham, Massachusetts, who were initially free of coronary heart disease has been monitored. At entry the subjects were between 30 and 62 years of age. Body weight was measured at entry and every two years thereafter at regular follow-up examinations; body weight at 25 years of age as recalled by the subjects was also recorded. The details of sampling, response rates, methods, and follow-up have been described in detail,5 and the results of the 24-year follow-up have been reported in a comprehensive review.6 This new analysis is based on data from 32 years of follow-up. Other investigators have previously used these data to address questions on the relation of obesity, weight loss, and weight gain to various health end points.7 , 8

Chronology

In order to study the relations between fluctuations in weight and chronic disease, it is important to understand the temporal sequence of weight change and onset of disease. The design for this analysis entailed a chronologic separation of weight change and health end points (Fig. 1Figure 1Chronology and Schematic Representation of Body-Weight Variables for a Hypothetical Subject.), by specifying the lengths of time required between determinations of body weight and end points included in the analyses. All measurements of body weight during the first 14 years of the Framingham Heart Study (eight follow-up examinations), along with each subject's recalled body weight at the age of 25, were used to construct independent variables representing body weight and its fluctuation. The subjects included in this analysis were examined at all of the first eight scheduled follow-up visits; those who missed any of these examinations were excluded. The dependent variables in our analyses were various end points occurring during a follow-up period that began at visit 10 — that is, at least four years after the last body-weight measurement was analyzed. The purpose of excluding earlier end points was to eliminate variability in body weight that might be attributed to antecedent disease. We also analyzed body weight in relation to the same end points after increasing the length of time required from the eighth follow-up examination to the first end points included in the analysis from four to six years.

Weight Cycling and Major Covariates

Weight cycling was defined on the basis of variability in each subject's body-mass index (the weight in kilograms divided by the square of the height in meters) during the period from the age of 25 (recalled weight) through the eighth biennial follow-up examination. A coefficient of variation for each subject's body-mass-index values was calculated at nine time points from the age of 25 through the eighth examination (Fig. 1). This value, which will be referred to as variability in weight, was calculated as the standard deviation of each subject's nine body-mass-index values divided by the average body-mass index for that subject. This variable reflects the extent to which a subject's body-mass index fluctuated around his or her own mean value. A high degree of variability in weight indicates many changes in weight or large changes, whereas a low value indicates stability of the body-weight values.

The two key covariates in this analysis were also within-subject variables. The first was a subject's mean body-mass index over the same nine time points. We call this a body-mass-index "level" to emphasize the fact that a value for this variable exists for each subject. The second covariate indicates the direction and magnitude of the change in a subject's body-mass index over the same period and is calculated as the change in the body-mass index per year ("slope"). A positive value indicates weight gain over time, whereas a negative value indicates weight loss.

Descriptive statistics for the key independent variables are shown in Table 1Table 1Characteristics of the Subjects during the Observation Period.*. For men and women, respectively, the average age at entry was 42.8 and 43.5 years. The average body-mass index (the mean of the individual means) was 25.9 for the men and 24.9 for the women, values that are based on mean body weights of 77.0 and 63.2 kg, respectively (data not shown). The mean values for the slope of the body-mass index indicate that both the men and the women gained weight at an average rate of 0.11 kg per square meter per year. Finally, the mean coefficients of variation suggest that women's weights tend to vary more than men's. A value of 0.06 indicates an average 6 percent deviation about a subject's mean body-mass index.

We had several reasons for including the level and slope of the body-mass index as covariates in this analysis. Because we included the slope of the body-mass index over time as an independent variable, it was possible to distinguish the effects of systematic change in body weight from the effects of random or periodic fluctuation. This distinction was necessary because the coefficient of variation of the body-mass index and the slope of the body-mass index are correlated (Table 1). Similarly, correcting for the level of the body-mass index enabled us to separate any effects of obesity from the effects of weight cycling. This was important because obese subjects are likely to have more fluctuation in weight induced by dieting than subjects who are not obese.

End Points

The four end points evaluated in relation to the degree of variability in body weight were total mortality, morbidity due to coronary heart disease, mortality from coronary heart disease, and morbidity due to cancer. Total mortality was determined and validated by a review of death certificates and other pertinent data from hospital records. Morbidity due to coronary heart disease was defined as angina pectoris, coronary insufficiency, myocardial infarction, sudden death, or death as a result of any other coronary heart disease identified on the basis of a review of the records by a panel of three physicians.5 Clinical, electrocardiographic, and enzymatic data were used to establish the diagnosis of myocardial infarction. Mortality from coronary heart disease was a subgroup of total morbidity due to coronary heart disease, as described above. Both categories included sudden death from coronary heart disease, which was defined as death in a subject who had apparently been well who died within 60 minutes of the onset of symptoms in the absence of any other cause. Morbidity due to cancer included all malignant neoplasms. The cases were documented by reviewing the records of all subjects suspected or known to have had cancer. The dates of diagnosis were ascertained and all pertinent data reviewed. Pathological or cytologic reports were available for all but a few potential cases. A supplemented format from the International Classification of Diseases for Oncology was used to encode topographic and morphologic features.9 , 10 Because of the relatively small number of cancers at specific sites, this group included all cases of cancer. The exclusion of subjects with skin cancer from this group did not alter the results.

To preserve the four-year intervals between the measurements of weight and health-outcome end points, any subject with a specific end point before the 10th examination was eliminated from the analysis of data on that particular outcome. As a result of these exclusions, the sample in this analysis was smaller than that of the original Framingham cohort.

Statistical Analysis

Proportional-hazards regression was used to analyze the data.11 Separate analyses were conducted for men and women, and all analyses were stratified to correct for age group at entry (30 through 44, 45 through 54, and 55 through 62 years). In the first analysis (Model A), each of the four outcome variables was modeled as a function of the variability of weight, with adjustment for age group. Next, the level of the body-mass index and the slope of the body-mass index over the same period were included with variability of weight in an age-adjusted multivariate model predicting each of the four outcomes (Model B). Finally, in Model C, a set of standard cardiovascular risk factors measured early in the study was added to the variables in the previous model. These were the number of cigarettes smoked daily, physical-activity level, serum cholesterol concentration, results of glucose-tolerance tests, and systolic blood pressure. Physical activity was assessed at the fourth examination; the other risk factors were measured in all subjects at the time of the first or second examination (or both), and the earliest available value for each subject was used.

The results for the three regression models are presented separately. Estimates of relative risk and the results of analyses in which we used an increasing interval between measurements of weight variability and end points, excluded recalled weight at 25 years of age, and stratified the data according to age are described separately. Two-tailed tests were used, and probability levels of less than 0.05 were considered to indicate statistical significance.

Results

Model A

In the first regression analysis (Model A), each of the four end points was modeled as a function of body-weight variability. As shown in Table 2Table 2Regression Coefficients and Significance Levels for Variability of Weight in Relation to Outcome, According to Models A and B.*, all end points except cancer were significantly related to the variability of body weight. All the significant regression coefficients were positive, indicating that a high degree of variability in body weight was associated with an increased risk of death from all causes, coronary heart disease, and death from coronary heart disease in both men and women.

Model B

In the next analysis (Model B), we added two covariates to the model that already included variability of weight in order to determine whether any of the significant effects of variability of weight could be accounted for by the average level or slope of a subject's body-mass index over time. The results of this analysis were largely consistent with those of the Model A analysis; in both men and women, variability of weight was significantly and positively associated with total mortality and mortality from coronary heart disease, but not with cancer (Table 2). Variation in weight remained a strong independent risk factor for total coronary heart disease in men. For the mortality and coronary heart disease end points, the regression coefficients of the level of the body-mass index were positive, and those of the slope of the body-mass index were negative (data not shown).

Model C

In Model C we added a set of standard cardiovascular risk factors to the independent variables included in Model B, in order to determine whether the results were confounded by cigarette smoking, physical-activity level, serum cholesterol level, systolic blood pressure, or glucose tolerance. After correction for the slope and level of the body-mass index, along with these five cardiovascular-disease risk factors, all the end points that were correlated with variability of weight in the previous analysis remained correlated with it (Table 3Table 3Partial Regression Coefficients (β) and Significance Levels of Selected Independent Variables, According to Multivariate Analysis in Model C.*). Among men, death from all causes, coronary heart disease, and death from coronary heart disease all remained significantly associated with variability of weight. In women, significant positive associations remained for death from all causes and death from coronary heart disease.

One of these risk factors, cigarette smoking, was examined in greater detail to determine whether the associations between fluctuation in weight and the health end points were dependent on smoking. We found, first, that the results from Model B were unaffected by the inclusion of cigarette smoking as the only additional covariate, indicating that cigarette smoking was not a significant confounding factor in this analysis. Second, we found no significant or suggestive statistical interactions between variability of weight and smoking in the prediction of coronary heart disease, death from coronary heart disease, or death from all causes, indicating that base-line smoking status did not modify the observed associations.

Estimates of Relative Risk

For purposes of illustration and to assist in the interpretation of the regression coefficients presented in Tables 2 and 3, we calculated the relative risk of each end point among the subjects whose weights were most variable (upper third), as compared with those whose weights varied least (lower third). This was done by dividing the group of subjects into thirds according to weight variability, calculating the mean values for the high-variability and low-variability groups, and applying proportional-hazards regression analysis to the distance between these points. As shown in Table 4Table 4Age-Adjusted Relative Risk of Each Outcome for the Subjects with the Highest Degree of Variability of Weight, as Compared with Those with the Least Variable Weights.*, the relative-risk estimates for total mortality and both coronary heart disease end points were between 1.27 and 2.00 and tended to be higher for men than for women. However, the lower 95 percent confidence limit was less than 1 in the multivariate model describing coronary heart disease in women and that describing cancer in men and women; these findings are in agreement with the results of the analyses in which weight variability was treated as a continuous variable.

Six-Year Intervals

The Model B analysis was repeated after we increased the length of time required between the eighth examination and the first occurrence in the study of death, coronary heart disease, or death from coronary heart disease. The number of end points included in this analysis was smaller than before, but the likelihood that the end points were determinants rather than consequences of the fluctuation in weight was also smaller. When the interval required for the inclusion of end points was increased from four to six years, the regression coefficients were similar; the average deviation from the original values was 11.5 percent. All previously significant outcomes remained significant after the extension of this interval except death from coronary heart disease among women (P = 0.07). Therefore, the associations became statistically weaker but did not decrease appreciably in magnitude when we used a more conservative chronology for independent and dependent variables.

Recalled Weight at 25 Years of Age

We included the recalled weight at the age of 25 in the calculation of body-weight variability for several reasons. The first was that subjects' reports of their body weight are fairly accurate.12 More important, changes in body weight during young adulthood may have important implications for health in later life and may be captured, at least partially, by using the weight at 25 years of age. Nonetheless, we repeated the Model B analysis after excluding the weight at the age of 25 from the calculation of variability of weight. The association with total mortality remained statistically significant for both men (P = 0.0003) and women (P = 0.0008), as did that with death from coronary heart disease among women (P = 0.0002). Although the other coronary heart disease end points were no longer significantly related to variability of weight, the direction of the associations was the same. These results suggest that weight at 25 years of age makes an important contribution to the total variance of individual subjects' weight, which is likely to reflect true change in addition to inaccuracies in self-reporting.

Results According to Age Groups

Although the associations already described were found in analyses in which the three defined age groups were pooled, the results were also considered for each age group individually. The strongest and most consistent associations between weight variability and the health end points were found in the youngest age groups (men and women 30 through 44 years of age).

Discussion

These results indicate that persons whose body weight fluctuates often or greatly have a higher risk of coronary heart disease and death than do persons with relatively stable body weights. The associations observed were generally independent of both weight for height and temporal trends in weight, as well as of a number of cardiovascular risk factors. Therefore, it appears that body-weight variability, together with obesity, the overall trend in body weight, and other known risk factors for disease, has value in predicting the risk of mortality and coronary heart disease.

The relative risks attributable to fluctuation in weight were comparable in magnitude to the risks attributable to being overweight for total mortality,13 cardiovascular disease,8 and coronary heart disease.6 Recalled body weight at the age of 25 did not affect the associations between fluctuation in weight and mortality from all causes, but it was important in some of the associations with coronary heart disease, suggesting that weight changes in early adulthood may have different health implications from subsequent weight changes. Although not central to this analysis, systematic weight change (as measured by the slope of the body-mass index) was inversely associated with many of the end points examined here. Further research is needed to examine the independent effects of systematic weight change and variability of weight.

The associations reported here may be interpreted in a number of different ways. One possibility is that many of the subjects who died or were given diagnoses of disease during follow-up were already ill when their body weight was measured. In this case, the fluctuations in weight could be the consequence, and not the cause, of the health end points. However, the intervals between each subject's last body-weight measurement and any end point included in our analyses were intended to exclude serious preexisting illnesses that might have affected weight. Furthermore, we controlled for unidirectional trends in body weight in order to diminish the effect of systematic weight loss (presumably associated with chronic illness) on the associations observed. Certain diseases, such as gastrointestinal disorders and alcoholism, may be associated with periodic fluctuations in weight rather than with systematic losses or gains, but this pattern is probably less characteristic of most illnesses than is weight loss alone. These observations decrease the plausibility of the explanation that the subjects' weight fluctuated because they were already seriously ill.

An alternative possibility is that subjects with risk factors for coronary heart disease are the most likely to be put on weight-loss regimens (and thereby to have weight loss or loss-regain patterns), but that these changes would not reverse the health risks they already face. We attempted to minimize this possibility by including the earliest available values for five risk factors for cardiovascular disease in the multivariate analysis. Furthermore, the absence of a significant interaction between variability of weight and smoking in the prediction of the health end points suggests that these associations do not vary significantly between smokers and nonsmokers.

Finally, these results may reflect an adverse effect of voluntary weight loss and subsequent relapse. Although adherence to weight-reduction diets was not routinely documented at the Framingham examinations, another study indicated that body-weight variability was significantly correlated with a history of dieting.2 In addition, our review of selected medical records from the Framingham Heart Study indicated that dieting was common among subjects whose body weights varied. Specifically, in a review of the medical charts of the 40 subjects with the greatest variability in body weight (corrected for the level and slope of the body-mass index), we found that weight-reduction dieting was documented in 50 percent of these subjects before the eighth examination. This rate of dieting is likely to underestimate the true rate, since dieting was not recorded consistently. Therefore, dieting cannot be ruled out as an explanation of these findings, although its specific role can be elucidated only by prospective studies designed to collect this type of information.

If dieting emerges as a major factor in body-weight fluctuation, it may be important to evaluate further the public health implications of current weight-loss practices. Approximately 50 percent of American women and 25 percent of American men are dieting at any time,13 and many diets are unsuccessful. In view of the high rates of dieting, we wish to highlight two aspects of our results. First, weight fluctuation was most strongly associated with adverse health outcomes in the youngest cohort (age, 30 through 44 years). In addition to being the age category in which the results were least distorted by competing causes of illness, this is the age group in which dieting is likely to be most common. Second, because the relative risks associated with variation in weight were similar to those attributed to obesity, the risks due to excess weight may not outweigh the risks due to weight fluctuation. Although it would be premature to make clinical recommendations on the basis of our findings, these results do suggest that overweight persons should be taught skills to maintain weight loss and that the prevention of relapse should become a more central focus of weight-loss programs.14 , 15

These results underscore the difficulties of using epidemiologic data to study the effects of weight change on health and longevity. Despite uncertainties in interpreting the associations described here, our findings are strengthened by their consistency with those of two earlier studies involving body-weight variability and health.1 , 2 Together, these results raise the possibility that weight cycling by dietary means may have a role in the development of chronic disease.

Supported by grants from the MacArthur Foundation, the Dana Foundation, and the National Institutes of Health (MH00319, NOl-HC-38038, S-232CA09430, 236–86-C-033, and l-R01-HL-40423–01).

We are indebted to Drs. David Kritchevsky and George Blackburn for their helpful comments at various stages of this project.

Source Information

From the Department of Primary Health Care, Redbergsvägen #6, Göteborg, Sweden (L.L.); the Department of Mathematics, Bryant College, Smithfield, R.I. (P.M.O.); the Department of Mathematics, Boston University, Boston (R.B.D., A.J.B.); the Department of Preventive Medicine and Epidemiology, Boston University Medical Center, Boston (J.S., B.E.K.); and the Department of Psychology, Yale University, New Haven, Conn. (K.D.B.). Address reprint requests to Dr. Brownell at the Department of Psychology, Yale University, 2 Hillhouse Ave., Box 11A Yale Sta., New Haven, CT 06520.

References

References

  1. 1

    Hamm PB, Shekelle RB, Stamler J. Large fluctuations in body weight during young adulthood and twenty-five-year risk of coronary death in men . Am J Epidemiol 1989; 129:312–8.
    Web of Science | Medline

  2. 2

    Lissner L, Bengtsson C, Lapidus L, Larsson B, Bengtsson B, Brownell K. Body weight variability and mortality in the Gothenburg Prospective Studies of men and women. In: Björntorp P, Rossner S, eds. Obesity in Europe 88: Proceedings of the First European Congress on Obesity. London: Libbey, 1989:55–60.

  3. 3

    Stevens J, Lissner L. Body weight variability and mortality in the Charleston Heart Study . Int J Obes 1990; 14:385–6.
    Web of Science | Medline

  4. 4

    Lissner L, Andres R, Muller DC, Shimokata H. Body weight variability in men: metabolic rate, health and longevity . Int J Obes 1990; 14:373–83.
    Web of Science | Medline

  5. 5

    Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study . Am J Public Health 1951; 41:279–86.
    CrossRef | Web of Science

  6. 6

    Dawber TR. The Framingham Study: the epidemiology of atherosclerotic disease. Cambridge, Mass.: Harvard University Press, 1980.

  7. 7

    Ashley FW Jr, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study . J Chronic Dis 1974; 27:103–14.
    CrossRef | Medline

  8. 8

    Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study . Circulation 1983; 67:968–77.
    CrossRef | Web of Science | Medline

  9. 9

    World Health Organization. International classification of diseases for oncology. Geneva: World Health Organization, 1976.

  10. 10

    Percy C, O'Conor G, Ries LG, Jaffe ES. Non-Hodgkin's lymphomas: application of the international classification of diseases for oncology (ICD-O) to the Working Formulation . Cancer 1984; 54:1435–8.
    CrossRef | Web of Science | Medline

  11. 11

    SAS Institute Inc. Statistical analysis system, version 5 edition. Cary, N.C.: SAS Institute, 1986.

  12. 12

    Stunkard AJ, Albaum JM. The accuracy of self-reported weights . Am J Clin Nutr 1981;34:1593–9.
    Web of Science | Medline

  13. 13

    National Center for Health Statistics. Provisional data from the Health Promotion and Disease Prevention Supplement to the National Health Interview Survey: United States, January—March 1985. In: Advance data from vital and health statistics. No. 113. Hyattsville, Md.: Public Health Service, 1985:2–5. (DHHS publication no. (PHS) 86–1250.)

  14. 14

    Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT. Understanding and preventing relapse . Am Psychol 1986; 41:765–82.
    CrossRef | Web of Science | Medline

  15. 15

    Marlatt GA, Gordon J. Relapse prevention: maintenance strategies in addictive behavior change. New York: Guilford, 1985.

Citing Articles (124)

Citing Articles

  1. 1

    V. L. Stevens, E. J. Jacobs, J. Sun, A. V. Patel, M. L. McCullough, L. R. Teras, S. M. Gapstur. (2012) Weight Cycling and Mortality in a Large Prospective US Study. American Journal of Epidemiology
    CrossRef

  2. 2

    Caitlin O'Reilly, Judith Sixsmith. (2012) From Theory to Policy: Reducing Harms Associated with the Weight-Centered Health Paradigm. Fat Studies 1:1, 97-113
    CrossRef

  3. 3

    Erin A. Olson, Amanda J. Visek, Karen A. McDonnell, Loretta DiPietro. (2011) Thinness Expectations and Weight Cycling in a Sample of Middle-aged Adults. Eating Behaviors
    CrossRef

  4. 4

    Suzanne Phelan, Kris Jankovitz, Todd Hagobian, Barbara Abrams. (2011) Reducing excessive gestational weight gain: lessons from the weight control literature and avenues for future research. Women's Health 7:6, 641-661
    CrossRef

  5. 5

    Kasey L. Serdar, Suzanne E. Mazzeo, Karen S. Mitchell, Steven H. Aggen, Kenneth S. Kendler, Cynthia M. Bulik. (2011) Correlates of weight instability across the lifespan in a population-based sample. International Journal of Eating Disorders 44:6, 506-514
    CrossRef

  6. 6

    Kathryn E. Piehowski, Amy G. Preston, Debra L. Miller, Sharon M. Nickols-Richardson. (2011) A Reduced-Calorie Dietary Pattern Including a Daily Sweet Snack Promotes Body Weight Reduction and Body Composition Improvements in Premenopausal Women Who Are Overweight and Obese: A Pilot Study. Journal of the American Dietetic Association 111:8, 1198-1203
    CrossRef

  7. 7

    Sheng-Chia Chung, Mark A. Hlatky, Roslyn A. Stone, Jamal S. Rana, Jorge Escobedo, William J. Rogers, Joyce T. Bromberger, Sheryl F. Kelsey, Maria Mori Brooks. (2011) Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D). American Heart Journal 162:1, 184-192.e3
    CrossRef

  8. 8

    Manpreet S. Mundi, Michael D. Jensen. 2011. Primary Therapy for Obesity as the Treatment of Type 2 Diabetes. , 105-115.
    CrossRef

  9. 9

    Wei Chen, Sathanur R. Srinivasan, Litao Ruan, Hao Mei, Gerald S. Berenson. (2011) Adult Hypertension Is Associated With Blood Pressure Variability in Childhood in Blacks and Whites: The Bogalusa Heart Study. American Journal of Hypertension 24:1, 77-82
    CrossRef

  10. 10

    M. Werneck, R.C. Afonso, G.R. Coelho, C. Sboarini, M.P.V. Coelho, T. Thomé, L.F. Lisboa, B.H. Ferraz Neto. (2011) Obese and Nonobese Recipients Had Similar Need for Ventilatory Support After Liver Transplantation. Transplantation Proceedings 43:1, 165-169
    CrossRef

  11. 11

    P. Pajunen, E. Vartiainen, S. Mannisto, P. Jousilahti, T. Laatikainen, M. Peltonen. (2010) Intra-individual changes in body weight in population-based cohorts during four decades: the Finnish FINRISK study. The European Journal of Public Health
    CrossRef

  12. 12

    Yechiel Friedlander, Guo Li, Myriam Fornage, O. Dale Williams, Cora E. Lewis, Pamela Schreiner, Mark J. Pletcher, Daniel Enquobahrie, Michelle Williams, David S. Siscovick. (2010) Candidate Molecular Pathway Genes Related to Appetite Regulatory Neural Network, Adipocyte Homeostasis and Obesity: Results from the CARDIA Study. Annals of Human Genetics 74:5, 387-398
    CrossRef

  13. 13

    Kelly D. Brownell. (2010) The humbling experience of treating obesity: Should we persist or desist?. Behaviour Research and Therapy 48:8, 717-719
    CrossRef

  14. 14

    D. Nagaoka, Y. Mitsuhashi, R. Angell, K. E. Bigley, J. E. Bauer. (2010) Re-induction of obese body weight occurs more rapidly and at lower caloric intake in beagles. Journal of Animal Physiology and Animal Nutrition 94:3, 287-292
    CrossRef

  15. 15

    Ken Fujioka. (2010) Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12:3, 186-194
    CrossRef

  16. 16

    Molly E. Waring, Charles B. Eaton, Thomas M. Lasater, Kate L. Lapane. (2010) Correlates of Weight Patterns during Middle Age Characterized by Functional Principal Components Analysis. Annals of Epidemiology 20:3, 201-209
    CrossRef

  17. 17

    A. M. Arnold, A. B. Newman, M. Cushman, J. Ding, S. Kritchevsky. (2010) Body Weight Dynamics and Their Association With Physical Function and Mortality in Older Adults: The Cardiovascular Health Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65A:1, 63-70
    CrossRef

  18. 18

    Hyun-Jeong Yoo, Bom-Taeck Kim, Yong-Woo Park, Kyung-Hee Park, Chan-Won Kim, Nam-Seok Joo. (2010) Difference of Body Compositional Changes According to the Presence of Weight Cycling in a Community-based Weight Control Program. Journal of Korean Medical Science 25:1, 49
    CrossRef

  19. 19

    Alison Gustafson, Olga Khavjou, Sally C. Stearns, Thomas C. Keyserling, Ziya Gizlice, Sara Lindsley, Kathy Bramble, Beverly Garcia, Larry Johnston, Julie Will, Patricia Poindexter, Alice S. Ammerman, Carmen D. Samuel-Hodge. (2009) Cost-effectiveness of a behavioral weight loss intervention for low-income women: The Weight-Wise Program. Preventive Medicine 49:5, 390-395
    CrossRef

  20. 20

    Barbara J. Messinger-Rapport, David R. Thomas, Julie K. Gammack, John E. Morley. (2009) Clinical Update on Nursing Home Medicine: 2009. Journal of the American Medical Directors Association 10:8, 530-553
    CrossRef

  21. 21

    T. E. Strandberg, A. Y. Strandberg, V. V. Salomaa, K. H. Pitkala, R. S. Tilvis, J. Sirola, T. A. Miettinen. (2009) Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men. European Heart Journal 30:14, 1720-1727
    CrossRef

  22. 22

    Irene Strychar, Marie-Ève Lavoie, Lyne Messier, Antony D. Karelis, Éric Doucet, Denis Prud'homme, Jonathan Fontaine, Rémi Rabasa-Lhoret. (2009) Anthropometric, Metabolic, Psychosocial, and Dietary Characteristics of Overweight/Obese Postmenopausal Women with a History of Weight Cycling: A MONET (Montreal Ottawa New Emerging Team) Study. Journal of the American Dietetic Association 109:4, 718-724
    CrossRef

  23. 23

    Tara L. LaRowe, Megan E. Piper, Tanya R. Schlam, Michael C. Fiore, Timothy B. Baker. (2009) Obesity and Smoking: Comparing Cessation Treatment Seekers With the General Smoking Population. Obesity
    CrossRef

  24. 24

    David R Thomas. (2008) Unintended weight loss in older persons. Aging Health 4:2, 191-200
    CrossRef

  25. 25

    A-C Vergnaud, S Bertrais, J-M Oppert, L Maillard-Teyssier, P Galan, S Hercberg, S Czernichow. (2008) Weight fluctuations and risk for metabolic syndrome in an adult cohort. International Journal of Obesity 32:2, 315-321
    CrossRef

  26. 26

    Byungsu Kim, Soo-Jung Kim, Jung-In Son, Yeon Ho Joo. (2008) Weight change in the acute treatment of bipolar I disorder: A naturalistic observational study of psychiatric inpatients. Journal of Affective Disorders 105:1-3, 45-52
    CrossRef

  27. 27

    C L Chei, H Iso, K Yamagishi, M Inoue, S Tsugane. (2008) Body mass index and weight change since 20 years of age and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based Study. International Journal of Obesity 32:1, 144-151
    CrossRef

  28. 28

    A. G. Shaper. 2007. Obesity and Cardiovascular Disease. , 90-107.
    CrossRef

  29. 29

    Peter Rzehak, Christa Meisinger, Gabriele Woelke, Sabine Brasche, Gert Strube, Joachim Heinrich. (2007) Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. European Journal of Epidemiology 22:10, 665-673
    CrossRef

  30. 30

    Nguyen D Nguyen, Jacqueline R Center, John A Eisman, Tuan V Nguyen. (2007) Bone Loss, Weight Loss, and Weight Fluctuation Predict Mortality Risk in Elderly Men and Women. Journal of Bone and Mineral Research 22:8, 1147-1154
    CrossRef

  31. 31

    David R. Thomas. (2007) Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia. Clinical Nutrition 26:4, 389-399
    CrossRef

  32. 32

    Ingar Holme, Anne Johanne Sogaard, Lise Lund Haheim, Per G Lund Larsen, Serena Tonstad. (2007) Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study. Metabolic Syndrome and Related Disorders 5:2, 127-135
    CrossRef

  33. 33

    Z. Li, K. Hong, E. Wong, M. Maxwell, D. Heber. (2007) Weight cycling in a very low-calorie diet programme has no effect on weight loss velocity, blood pressure and serum lipid profile. Diabetes, Obesity and Metabolism 9:3, 379-385
    CrossRef

  34. 34

    (2007) Données épidémiologiques. Obésité 2:1, 21-31
    CrossRef

  35. 35

    Gretchen Van Wye, Joel A. Dubin, Steven N. Blair, Loretta Di Pietro. (2007) Weight Cycling and 6-Year Weight Change in Healthy Adults: The Aerobics Center Longitudinal Study*. Obesity 15:3, 731-739
    CrossRef

  36. 36

    Alexandra Zauner, Petra Nimmerrichter, Christian Anderwald, Martin Bischof, Mark Schiefermeier, Klaus Ratheiser, Bruno Schneeweiss, Christian Zauner. (2007) Severity of insulin resistance in critically ill medical patients. Metabolism 56:1, 1-5
    CrossRef

  37. 37

    J-P Montani, A K Viecelli, A Prévot, A G Dulloo. (2006) Weight cycling during growth and beyond as a risk factor for later cardiovascular diseases: the ‘repeated overshoot’ theory. International Journal of Obesity 30, S58-S66
    CrossRef

  38. 38

    A G Dulloo, J Jacquet, J Seydoux, J-P Montani. (2006) The thrifty ‘catch-up fat’ phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. International Journal of Obesity 30, S23-S35
    CrossRef

  39. 39

    S E Saarni, A Rissanen, S Sarna, M Koskenvuo, J Kaprio. (2006) Weight cycling of athletes and subsequent weight gain in middleage. International Journal of Obesity 30:11, 1639-1644
    CrossRef

  40. 40

    Cintia Curioni, Charles Andr, Cintia Curioni. 2006. Rimonabant for overweight or obesity. .
    CrossRef

  41. 41

    Cintia Curioni, Charles André, Renato Veras, Cintia Curioni. 2006. Weight reduction for primary prevention of stroke in adults with overweight or obesity. .
    CrossRef

  42. 42

    M Clark. (2006) Weight management for the obese patient in primary care: is a commercially available weight loss programme the answer?. Practical Diabetes International 23:3, 123-127
    CrossRef

  43. 43

    Alexandra Zauner, Bruno Schneeweiss, Nikolaus Kneidinger, Gregor Lindner, Christian Zauner. (2006) Weight-adjusted resting energy expenditure is not constant in critically ill patients. Intensive Care Medicine 32:3, 428-434
    CrossRef

  44. 44

    Jennie L Wells, Andrea C Dumbrell. (2006) Nutrition and aging: assessment and treatment of compromised nutritional status in frail elderly patients. Clinical Interventions in Aging 1:1, 67-79
    CrossRef

  45. 45

    A. G. Dulloo. (2005) A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome. Acta Physiologica Scandinavica 184:4, 295-307
    CrossRef

  46. 46

    Michael D. Knudtson, Barbara E.K. Klein, Ronald Klein, Anoop Shankar. (2005) Associations with Weight Loss and Subsequent Mortality Risk. Annals of Epidemiology 15:7, 483-491
    CrossRef

  47. 47

    J. S. Lee, S. B. Kritchevsky, F. Tylavsky, T. Harris, E. M. Simonsick, S. M. Rubin, A. B. Newman, . (2005) Weight Change, Weight Change Intention, and the Incidence of Mobility Limitation in Well-Functioning Community-Dwelling Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:8, 1007-1012
    CrossRef

  48. 48

    Vanessa A. Diaz, Arch G. Mainous, Charles J. Everett. (2005) THE ASSOCIATION BETWEEN WEIGHT FLUCTUATION AND MORTALITY: RESULTS FROM A POPULATION-BASED COHORT STUDY. Journal of Community Health 30:3, 153-165
    CrossRef

  49. 49

    L. Lissner. 2005. WEIGHT MANAGEMENT | Weight Cycling. , 421-427.
    CrossRef

  50. 50

    Huiming Zhang, Koji Tamakoshi, Hiroshi Yatsuya, Chiyoe Murata, Keiko Wada, Rei Otsuka, Nobue Nagasawa, Miyuki Ishikawa, Kaichiro Sugiura, Kunihiro Matsushita, Yoko Hori, Takaaki Kondo, Hideaki Toyoshima. (2005) Long-Term Body Weight Fluctuation is Associated With Metabolic Syndrome Independent of Current Body Mass Index Among Japanese Men. Circulation Journal 69:1, 13-18
    CrossRef

  51. 51

    Solomon, Caren G., Dluhy, Robert G., . (2004) Bariatric Surgery — Quick Fix or Long-Term Solution?. New England Journal of Medicine 351:26, 2751-2753
    Full Text

  52. 52

    Dennis H. Sullivan, Longjian Liu, Paula K. Roberson, Melinda M. Bopp, Jacqueline C. Rees. (2004) Body Weight Change and Mortality in a Cohort of Elderly Patients Recently Discharged from the Hospital. Journal of the American Geriatrics Society 52:10, 1696-1701
    CrossRef

  53. 53

    Marie Clark. (2004) Is weight loss a realistic goal of treatment in type 2 diabetes?. Patient Education and Counseling 53:3, 277-283
    CrossRef

  54. 54

    Pierre Chue, Christopher S Kovacs. (2003) Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management. Bipolar Disorders 5:s2, 62-79
    CrossRef

  55. 55

    Jonathan Webber. (2003) Energy balance in obesity. Proceedings of the Nutrition Society 62:02, 539-543
    CrossRef

  56. 56

    Rita Hiller, Robert D Sperduto, George F Reed, Ralph B D’Agostino, Peter W.F Wilson. (2003) Serum lipids and age-related lens opacities: A longitudinal investigation. Ophthalmology 110:3, 578-583
    CrossRef

  57. 57

    Nicole M. Wedick, Elizabeth Barrett-Connor, James D. Knoke, Deborah L. Wingard. (2002) The Relationship Between Weight Loss and All-Cause Mortality in Older Men and Women With and Without Diabetes Mellitus: The Rancho Bernardo Study. Journal of the American Geriatrics Society 50:11, 1810-1815
    CrossRef

  58. 58

    U. Werneke, D. Taylor, T.A.B. Sanders. (2002) Options for pharmacological management of obesity in patients treated with atypical antipsychotics. International Clinical Psychopharmacology 17:4, 145-160
    CrossRef

  59. 59

    G. Mingrone, A.V. Greco, A. Giancaterini, A. Scarfone, M. Castagneto, M. Pugeat. (2002) Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. Atherosclerosis 161:2, 455-462
    CrossRef

  60. 60

    Devendra Singh, Valerie C. Rosen. (2001) Effects of maternal body morphology, morning sickness, gestational diabetes and hypertension on fluctuating asymmetry in young women. Evolution and Human Behavior 22:6, 373-384
    CrossRef

  61. 61

    Anne B. Newman, David Yanez, Tamara Harris, Andrew Duxbury, Paul L. Enright, Linda P. Fried, . (2001) Weight Change in Old Age and its Association with Mortality. Journal of the American Geriatrics Society 49:10, 1309-1318
    CrossRef

  62. 62

    Justin Kenardy, Wendy J Brown, Emma Vogt. (2001) Dieting and health in young Australian women. European Eating Disorders Review 9:4, 242-254
    CrossRef

  63. 63

    David C. Grabowski, John E. Ellis. (2001) High Body Mass Index Does Not Predict Mortality in Older People: Analysis of the Longitudinal Study of Aging. Journal of the American Geriatrics Society 49:7, 968-979
    CrossRef

  64. 64

    M.-M. G. Wilson. (2001) Guest Editorial: Bitter-Sweet Memories: Truth and Fiction. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:4, M196-M199
    CrossRef

  65. 65

    I-M. Lee, S. N. Blair, D. B. Allison, A. R. Folsom, T. B. Harris, J. E. Manson, R. R. Wing. (2001) Epidemiologic Data on the Relationships of Caloric Intake, Energy Balance, and Weight Gain Over the Life Span With Longevity and Morbidity. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:Supplement 1, 7-19
    CrossRef

  66. 66

    Marian B Olson, Sheryl F Kelsey, Vera Bittner, Steven E Reis, Nathaniel Reichek, Eileen M Handberg, C.Noel Bairey Merz. (2000) Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect. Journal of the American College of Cardiology 36:5, 1565-1571
    CrossRef

  67. 67

    Gary D. Miller, Alison G. Dimond, Judith S. Stern. (2000) The Effect of Repeated Episodes of Dietary Restriction and Refeeding on Systolic Blood Pressure and Food Intake in Exercise-Trained Normotensive Rats. Obesity 8:4, 324-336
    CrossRef

  68. 68

    Helga Nauta, Harm Hospers, Gerjo Kok, Anita Jansen. (2000) A comparison between a cognitive and a behavioral treatment for obese binge eaters and obese non-binge eaters. Behavior Therapy 31:3, 441-461
    CrossRef

  69. 69

    Birgit-Christiane Zyriax, Eberhard Windler. (2000) Dietary fat in the prevention of cardiovascular disease — a review. European Journal of Lipid Science and Technology 102:5, 355-365
    CrossRef

  70. 70

    W. J. Strawbridge, M. I. Wallhagen, S. J. Shema. (2000) New NHLBI clinical guidelines for obesity and overweight: will they promote health?. American Journal of Public Health 90:3, 340-343
    CrossRef

  71. 71

    G Oster, D Thompson, J Edelsberg, A P Bird, G A Colditz. (1999) Lifetime health and economic benefits of weight loss among obese persons.. American Journal of Public Health 89:10, 1536-1542
    CrossRef

  72. 72

    Mary A. Steinhardt, Janet R. Bezner, Troy B. Adams. (1999) Outcomes of a Traditional Weight Control Program and a Nondiet Alternative: A One-Year Comparison. The Journal of Psychology 133:5, 495-513
    CrossRef

  73. 73

    C. Keith Haddock, Risa J. Stein, Walker S. C. Poston, Robert C. Klesges, Gerald W. Talcott, Harry Lando. (1999) Prevalence and Risk Factors for Frequent Dieting and Weight Concerns Among U.S. Air Force Personnel. Eating Disorders 7:2, 83-97
    CrossRef

  74. 74

    A. GASTALDELLI, R. MAMMOLITI, E. MUSCELLI, S. CAMASTRA, L. LANDINI, E. FERRANNINI, M. EMDIN. (1999) Linear and Nonlinear Properties of Heart Rate Variability: Influence of Obesity. Annals of the New York Academy of Sciences 879:1 TEMPOS IN SCI, 249-254
    CrossRef

  75. 75

    Paul Ernsberger, Richard J. Koletsky, Ahmad Kilani, Gita Viswan, David Bedol. (1998) Effects of weight cycling on urinary catecholamines. Journal of Hypertension 16:Supplement, 2001-2005
    CrossRef

  76. 76

    Les C. Higgins, Wendy Gray. (1998) Changing the body image concern and eating behaviour of chronic dieters: The effects of a psychoeducational intervention. Psychology & Health 13:6, 1045-1060
    CrossRef

  77. 77

    GLORIA J KENSINGER, MAUREEN A MURTAUGH, SIMONA K REICHMANN, CHRISTINE C TANGNEY. (1998) Psychological Symptoms are Greater Among Weight Cycling Women with Severe Binge Eating Behavior. Journal of the American Dietetic Association 98:8, 863-868
    CrossRef

  78. 78

    Rita Hiller, Marvin J Podgor, Robert D Sperduto, Leila Nowroozi, Peter W.F Wilson, Ralph B D’Agostino, Theodore Colton. (1998) A longitudinal study of body mass index and lens opacities. Ophthalmology 105:7, 1244-1250
    CrossRef

  79. 79

    Alexander R.P. Walker. (1998) Epidemiology and health implications of obesity, with special reference to African populations. Ecology of Food and Nutrition 37:1, 21-55
    CrossRef

  80. 80

    Jennifer O'Loughlin, Gilles Paradis, Garbis Meshefedjian, Natalie Kishchuk. (1998) Evaluation of an 8-Week Mailed Healthy-Weight Intervention. Preventive Medicine 27:2, 288-295
    CrossRef

  81. 81

    Kassirer, Jerome P., Angell, Marcia, . (1998) Losing Weight — An Ill-Fated New Year's Resolution. New England Journal of Medicine 338:1, 52-54
    Full Text

  82. 82

    SACHIKO T ST JEOR. (1997) New Trends in Weight Management. Journal of the American Dietetic Association 97:10, 1096-1098
    CrossRef

  83. 83

    Curfman, Gregory D., . (1997) Diet Pills Redux. New England Journal of Medicine 337:9, 629-630
    Full Text

  84. 84

    Tamina Toray, Eric Cooley. (1997) Weight Fluctuation, Bulimic Symptoms, and Self-Efficacy for Control of Eating. The Journal of Psychology 131:4, 383-392
    CrossRef

  85. 85

    Yechiel Friedlander, Melissa A. Austin, Beth Newman, Karen Edwards, Elizabeth J. Mayer-Davis, Mary-Claire King. (1997) Heritability of Longitudinal Changes in Coronary-Heart-Disease Risk Factors in Women Twins. The American Journal of Human Genetics 60:6, 1502-1512
    CrossRef

  86. 86

    SACHIKO T. ST JEOR, ROBERT L. BRUNNER, MELANIE E. HARRINGTON, BARBARA J. SCOTT, SANDRA A. DAUGHERTY, GARY R. CUTTER, KELLY D. BROWNELL, ALAN R. DYER, JOHN P. FOREYT. (1997) A Classification System to Evaluate Weight Maintainers, Gainers, and Losers. Journal of the American Dietetic Association 97:5, 481-488
    CrossRef

  87. 87

    William B. Kannel. (1997) Effect of weight on cardiovascular disease. Nutrition 13:2, 157-158
    CrossRef

  88. 88

    Cynthia L. Arfken, Cheryl A. Houston. (1996) Obesity in Inner‐city African Americans. Ethnicity & Health 1:4, 317-326
    CrossRef

  89. 89

    David F. Williamson. (1996) Lingering questions about intentional weight loss. Nutrition 12:11-12, 819-820
    CrossRef

  90. 90

    Lauren Lissner. (1996) Health consequences of weight cycling? An open question. Nutrition Bulletin 21:2, 95-101
    CrossRef

  91. 91

    Z Chen. (1995) Weight cycling-induced reduction of linoleic acid in carcass and adipose tissue in rats. The Journal of Nutritional Biochemistry 6:12, 653-660
    CrossRef

  92. 92

    Daniel S. Kirschenbaum, Marian L. Fitzgibbon. (1995) Controversy about the treatment of obesity: Criticisms or challenges?. Behavior Therapy 26:1, 43-68
    CrossRef

  93. 93

    Iribarren, Carlos, Sharp, Dan S., Burchfiel, Cecil M., Petrovitch, Helen, . (1995) Association of Weight Loss and Weight Fluctuation with Mortality among Japanese American Men. New England Journal of Medicine 333:11, 686-692
    Full Text

  94. 94

    Martin G. Larson. (1995) Assessment of cardiovascular risk factors in the elderly: The Framingham heart study. Statistics in Medicine 14:16, 1745-1756
    CrossRef

  95. 95

    (1995) Put Prevention Into Practice.. Journal of the American Academy of Nurse Practitioners 7:7, 339-344
    CrossRef

  96. 96

    Jane Vigus, Philip Tata, Pat Judd, Carole Bowyert, Elizabeth Evans. (1995) Which way to treat obesity? Emotional, eating and behavioural issues in dieting. Journal of Human Nutrition and Dietetics 8:2, 105-118
    CrossRef

  97. 97

    John P. Foreyt, Robert L. Brunner, G. Ken Goodrick, Gary Cutter, Kelly D. Brownell, Sachiko T. St. Jeor. (1995) Psychological correlates of weight fluctuation. International Journal of Eating Disorders 17:3, 263-275
    CrossRef

  98. 98

    DARLENE ZIMMERMAN, SHARON L. HOERR. (1995) Use of Questionable Dieting Practices among Young Women Examined by Weight History. Journal of Women's Health 4:2, 189-196
    CrossRef

  99. 99

    Peter N. Benotti, R. Armour Forse. (1995) The role of gastric surgery in the multidisciplinary management of severe obesity. The American Journal of Surgery 169:3, 361-367
    CrossRef

  100. 100

    Jane Ogden. (1994) Restraint theory and its implications for obesity treatment. Clinical Psychology & Psychotherapy 1:4, 191-201
    CrossRef

  101. 101

    Karen M. Carrier, Mary A. Steinhardt, Sally Bowman. (1994) Rethinking Traditional Weight Management Programs: A 3-Year Follow-Up Evaluation of a New Approach. The Journal of Psychology 128:5, 517-535
    CrossRef

  102. 102

    David Crawford, Neville Owen. (1994) The behavioural epidemiology of weight control. Australian Journal of Public Health 18:2, 143-148
    CrossRef

  103. 103

    Gail Haus, Sharon L Hoerr, Brian Mavis, Jon Robison. (1994) Key modifiable factors in weight maintenance: Fat intake, exercise, and weight cycling. Journal of the American Dietetic Association 94:4, 409-413
    CrossRef

  104. 104

    Linda Smolak, Michael P. Levine. (1994) Toward an Empirical Basis for Primary Prevention of Eating Problems with Elementary School Children. Eating Disorders 2:4, 293-307
    CrossRef

  105. 105

    Gary D. Foster, Philip C. Kendall. (1994) The realistic treatment of obesity: Changing the scales of success. Clinical Psychology Review 14:8, 701-736
    CrossRef

  106. 106

    Robert L. Brunner, Sachiko T. St. Jeor, Barbara J. Scott, Grant D. Miller, Timothy P. Carmody, Kelly D. Brownell, John Foreyt. (1994) Dieting and Disordered Eating Correlates of Weight Fluctuation in Normal And Obese Adults. Eating Disorders 2:4, 341-356
    CrossRef

  107. 107

    Anna B. Tang, Karen Y. Nishimura, Stephen D. Phinney. (1993) Preferential reduction in adipose tissue α-linolenic acid (183ω3) during very low calorie dieting despite supplementation with 183ω3. Lipids 28:11, 987-993
    CrossRef

  108. 108

    FIMA LIFSHITZ. (1993) Fear of Obesity in Childhood. Annals of the New York Academy of Sciences 699:1 Prevention an, 230-236
    CrossRef

  109. 109

    Linda J. McCargar, Deanna Simmons, Neil Craton, Jack E. Taunton, C. Laird Birmingham. (1993) Physiological Effects of Weight Cycling in Female Lightweight Rowers. Canadian Journal of Applied Physiology 18:3, 291-303
    CrossRef

  110. 110

    Anne Halliday. (1993) 1 Weight cycling and mortality. Nutrition Bulletin 18:3, 148-150
    CrossRef

  111. 111

    Catherine Rumpel, Tamara B. Harris, Jennifer Madans. (1993) Modification of the relationship between the Quetelet index and mortality by weight-loss history among older women. Annals of Epidemiology 3:4, 343-350
    CrossRef

  112. 112

    Ness, Roberta B.Harris, TamaraCobb, JanetFlegal, Katherine M.Kelsey, Jennifer L.Balanger, AlbertStunkard, Albert J.D'Agostino, Ralph B.. (1993) Number of Pregnancies and the Subsequent Risk of Cardiovascular Disease. New England Journal of Medicine 328:21, 1528-1533
    Full Text

  113. 113

    Jonathan I Robison, Sharon L Hoerr, John Strandmark, Brian Mavis. (1993) Obesity, weight loss, and health. Journal of the American Dietetic Association 93:4, 445-449
    CrossRef

  114. 114

    Thomas N. Robinson. (1993) Defining obesity in children and adolescents: Clinical approaches. Critical Reviews in Food Science and Nutrition 33:4-5, 313-320
    CrossRef

  115. 115

    J.M. Kuyl, M. Slabber, H.C. Barnard, H.J. van Wyk, A.M. Badenhorst. (1992) Observed changes in the plasma glucose, insulin, and C-peptide response after an oral glucose load, and plasma lipid and fibrinogen levels in morbidly obese females during a prolonged calorie-restricted diet. Clinical Biochemistry 25:5, 336-337
    CrossRef

  116. 116

    Brenda L. Wolfe. (1992) Long-term maintenance following attainment of goal weight: A preliminary investigation. Addictive Behaviors 17:5, 469-477
    CrossRef

  117. 117

    D F Williamson, M K Serdula, R F Anda, A Levy, T Byers. (1992) Weight loss attempts in adults: goals, duration, and rate of weight loss.. American Journal of Public Health 82:9, 1251-1257
    CrossRef

  118. 118

    J.S Garrow. (1992) Treatment of obesity. The Lancet 340:8816, 409-413
    CrossRef

  119. 119

    MYRNA M. WEISSMAN, MICHAEL FENDRICH, VIRGINIA WARNER, PRIYA WICKRAMARATNE. (1992) Incidence of Psychiatric Disorder in Offspring at High and Low Risk for Depression. Journal of the American Academy of Child & Adolescent Psychiatry 31:4, 640-648
    CrossRef

  120. 120

    Manson, JoAnn E., Tosteson, Heather, Ridker, Paul M., Satterfield, Suzanne, Hebert, Patricia, O'Connor, Gerald T., Buring, Julie E., Hennekens, Charles H., . (1992) The Primary Prevention of Myocardial Infarction. New England Journal of Medicine 326:21, 1406-1416
    Full Text

  121. 121

    Dennis J. Paulson, Arun G. Tahiliani. (1992) Cardiovascular abnormalities associated with human and rodent obesity. Life Sciences 51:20, 1557-1569
    CrossRef

  122. 122

    (1991) Variability of Body Weight and Health Outcomes. New England Journal of Medicine 325:24, 1745-1746
    Full Text

  123. 123

    Bouchard, Claude, . (1991) Is Weight Fluctuation a Risk Factor?. New England Journal of Medicine 324:26, 1887-1889
    Full Text

  124. 124

    HERBERT C. MANSMANN. (1991) Consider Magnesium Homeostasis. Pediatric Asthma, Allergy & Immunology 5:3, 273-279
    CrossRef

Letters